CCL19 and cervical cancer: CCL19 has also been shown to be overexpressed in cervical cancer tissue and cell lines with siRNA-induced a reduction in CCL19 inhibiting cervical cancer cell proliferation and increased levels of apoptosis, suggesting that CCL19 via CCR7 activation is a driving force of cervical cancer progression [94].